Topilsky Y, Maltais S, Inojosa JM et al (2019) Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 12(3):433–442
De la Espriella R, Santas E, Chorro FJ et al (2019) Functional tricuspid regurgitation and recurrent admissions in patients with acute heart failure. Int J Cardiol 15(291):83–88
Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. JACC 4(2004):405–409
Kawsara A, Alqahtani F, Nkomo VT et al (2021) Determinants of morbidity and mortality associated with isolated tricuspid valve surgery. J Am Heart Assoc 10:e018417
Article PubMed PubMed Central Google Scholar
Nickenig G, Weber M, Lurz P et al (2019) Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet 394:2002–2011
Vahanian A, Beyersdorf F, Praz F, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, DePaulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR,Tribouilloy C, Wojakowski W (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43(7):561–632. https://doi.org/10.1093/eurheartj/ehab395. Erratum in: Eur Heart J 43(21):2022. https://doi.org/10.1093/eurheartj/ehac051
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation. a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30(4):303–371. https://doi.org/10.1016/j.echo.2017.01.007
Hahn RT, Zamorano JL (2017) The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 18:1342–1343
Sorraja P, Whisenant B, Hamid N et al (2023) Transcatheter repair for patients with tricuspid regurgitation. NEJM. https://doi.org/10.1056/NEJMoa2300525
Kodali S, Hahn RT, Eleid MF et al (2021) Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol 77(4):345–356. https://doi.org/10.1016/j.jacc.2020.11.047
Pozzoli A, Zuber M, Reisman M et al (2018) Comparative anatomy of mitral and tricuspid valve: what can the intervention list learn from the surgeon. Front Cardiovasc Med 5:80. https://doi.org/10.3389/fcvm.2018.00080
Article PubMed PubMed Central Google Scholar
Eleid MF, Alkhouli M, Thaden JJ et al (2021) Utility of intracardiac echocardiography in the early experience of transcatheter edge to edge tricuspid valve repair. Circ Cardiovasc Interv 14(10):e011118
Sugiura A, Tanaka T, Kavsur R et al (2021) Leaflet configuration and residual tricuspid regurgitation after transcatheter edge-to-edge tricuspid repair. JACC Cardiovasc Interv 14(20):2260–2270
Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease. Circulation. 143(5):e35–e71
Patrascu A, Binder D, Ott I et al (2022) Transcatheter tricuspid valve repair in prohibitive risk patients: impact on quality of life and major organ systems. Can J Cardiol. https://doi.org/10.1016/j.cjca.2022.09.006
Hahn RT, Lawlor MK, Davidson CJ, et al. (2023) TVARC Steering Committee. Tricuspid valve academic research consortium definitions for tricuspid regurgitation and trial endpoints. J Am Coll Cardiol 82(17):1711–1735
Karam N, Braun D, Mehr M, et al (2019) Impact of transcatheter tricuspid valve repair for severe tricuspid regurgitation on kidney and liver function. J Am Coll Cardiol Intv 12(15):1413–1420
Ruf TF, Hahn RT, Kreidel F et al (2021) Short-term clinical outcomes of transcatheter tricuspid valve repair with the third-generation MitraClip XTR system. JACC Cardiovasc Interv 14(11):1231–1240
Besler C, Orban M, Rommel KP et al (2018) Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc Interv 11(12):1119–1128. https://doi.org/10.1016/j.jcin.2018.05.002
Nishiura N, Kitai T, Okada T et al (2023) Long-term clinical outcomes in patients with severe tricuspid regurgitation. J Am Heart Assoc 12(1):e025751. https://doi.org/10.1161/JAHA.122.025751
Adamo M, Pagnesi M, Ghizzoni G et al (2022) Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality. Eur J Heart Fail 24(11):2175–2184
Article PubMed PubMed Central Google Scholar
Stolz L, Doldi PM, Kresoja KP et al (2024) Applying the TRILUMINATE eligibility criteria to real-world patients receiving tricuspid valve transcatheter edge-to-edge repair. JACC Cardiovasc Interv 17(4):535–548
Gerçek M, Goncharov A, Narang A et al (2023) Characterization of screen failures among patients evaluated for transcatheter tricuspid valve repair (TriSelect-Study). JACC Cardiovasc Interv 16(13):1579–1589
Comments (0)